Arthur E. Reyes

689 total citations
12 papers, 308 citations indexed

About

Arthur E. Reyes is a scholar working on Oncology, Radiology, Nuclear Medicine and Imaging and Molecular Biology. According to data from OpenAlex, Arthur E. Reyes has authored 12 papers receiving a total of 308 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Oncology, 7 papers in Radiology, Nuclear Medicine and Imaging and 5 papers in Molecular Biology. Recurrent topics in Arthur E. Reyes's work include Monoclonal and Polyclonal Antibodies Research (7 papers), CAR-T cell therapy research (3 papers) and Biosimilars and Bioanalytical Methods (2 papers). Arthur E. Reyes is often cited by papers focused on Monoclonal and Polyclonal Antibodies Research (7 papers), CAR-T cell therapy research (3 papers) and Biosimilars and Bioanalytical Methods (2 papers). Arthur E. Reyes collaborates with scholars based in United States, Mexico and United Kingdom. Arthur E. Reyes's co-authors include George Dutina, Thomas Ryll, Lynne Krummen, Tina Etcheverry, Anne Wong, Ben‐Quan Shen, Jean-Philippe Stéphan, Luc Desnoyers, Daniela Bumbaca and Mark S. Dennis and has published in prestigious journals such as Blood, Cancer Research and Clinical Cancer Research.

In The Last Decade

Arthur E. Reyes

10 papers receiving 276 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Arthur E. Reyes United States 7 203 152 59 54 51 12 308
Jyothsna Visweswaraiah United States 8 313 1.5× 208 1.4× 89 1.5× 34 0.6× 97 1.9× 13 471
Yuwen Linda Lin Switzerland 7 156 0.8× 161 1.1× 87 1.5× 13 0.2× 144 2.8× 8 356
Mika Kamata‐Sakurai Japan 6 145 0.7× 62 0.4× 60 1.0× 11 0.2× 81 1.6× 10 218
Shannon M. Wilson United States 6 175 0.9× 32 0.2× 71 1.2× 18 0.3× 43 0.8× 7 326
Eric J. Hsu United States 11 173 0.9× 61 0.4× 239 4.1× 39 0.7× 231 4.5× 18 460
Atsuhiko Maeda United States 7 275 1.4× 296 1.9× 48 0.8× 23 0.4× 164 3.2× 7 420
Stephen Jarantow United States 6 120 0.6× 86 0.6× 167 2.8× 78 1.4× 45 0.9× 7 328
Ruizhan Tong China 11 211 1.0× 35 0.2× 203 3.4× 17 0.3× 91 1.8× 20 450
Taylor Kalomeris United States 5 186 0.9× 75 0.5× 178 3.0× 59 1.1× 131 2.6× 12 399
Shihong Li United States 8 125 0.6× 100 0.7× 88 1.5× 30 0.6× 17 0.3× 16 340

Countries citing papers authored by Arthur E. Reyes

Since Specialization
Citations

This map shows the geographic impact of Arthur E. Reyes's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Arthur E. Reyes with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Arthur E. Reyes more than expected).

Fields of papers citing papers by Arthur E. Reyes

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Arthur E. Reyes. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Arthur E. Reyes. The network helps show where Arthur E. Reyes may publish in the future.

Co-authorship network of co-authors of Arthur E. Reyes

This figure shows the co-authorship network connecting the top 25 collaborators of Arthur E. Reyes. A scholar is included among the top collaborators of Arthur E. Reyes based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Arthur E. Reyes. Arthur E. Reyes is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

12 of 12 papers shown
1.
2.
Yadav, Daniela Bumbaca, Arthur E. Reyes, Priyanka Gupta, et al.. (2020). Complex formation of anti‐VEGF‐C with VEGF‐C released during blood coagulation resulted in an artifact in its serum pharmacokinetics. Pharmacology Research & Perspectives. 8(2). e00573–e00573. 3 indexed citations
3.
Ferl, Gregory Z., Arthur E. Reyes, Liping Sun, et al.. (2018). A Preclinical Population Pharmacokinetic Model for Anti‐CD20/CD3 T‐Cell‐Dependent Bispecific Antibodies. Clinical and Translational Science. 11(3). 296–304. 23 indexed citations
4.
Chen, Xiaocheng, Yvonne Chen, Mark S. Dennis, et al.. (2014). Pre-Clinical Characterization of T Cell-Dependent Bispecific Antibody Anti-CD79b/CD3 As a Potential Therapy for B Cell Malignancies. Blood. 124(21). 4507–4507. 3 indexed citations
5.
Xiang, Hong, Brendan C. Bender, Arthur E. Reyes, et al.. (2013). Onartuzumab (MetMAb): Using Nonclinical Pharmacokinetic and Concentration–Effect Data to Support Clinical Development. Clinical Cancer Research. 19(18). 5068–5078. 28 indexed citations
6.
Xiang, Hong, Arthur E. Reyes, Steve Eppler, Sean K. Kelley, & Lisa A. Damico‐Beyer. (2013). Death receptor 5 agonistic antibody PRO95780: preclinical pharmacokinetics and concentration–effect relationship support clinical dose and regimen selection. Cancer Chemotherapy and Pharmacology. 72(2). 405–415. 8 indexed citations
7.
Bumbaca, Daniela, Anne Wong, Arthur E. Reyes, et al.. (2011). Highly specific off-target binding identified and eliminated during the humanization of an antibody against FGF receptor 4. mAbs. 3(4). 376–386. 72 indexed citations
8.
Yeung, Yik A., Xiumin Wu, Arthur E. Reyes, et al.. (2010). A Therapeutic Anti–VEGF Antibody with Increased Potency Independent of Pharmacokinetic Half-life. Cancer Research. 70(8). 3269–3277. 56 indexed citations
9.
Bender, Brendan C., Hong Xiang, Arthur E. Reyes, et al.. (2008). 539 POSTER Translational pharmacokinetic (PK), pharmacodynamic (PD) modeling and simulation analysis of MetMAb. European Journal of Cancer Supplements. 6(12). 170–170. 1 indexed citations
10.
Xiang, Hong, Arthur E. Reyes, Brendan C. Bender, et al.. (2008). 528 POSTER Supporting MetMAb entry into the clinic with nonclinical pharmacokinetic (PK) and pharmacodynamic (PD) information. European Journal of Cancer Supplements. 6(12). 167–167. 1 indexed citations
11.
12.
Recio, R., J. Garza‐Flores, Raffaela Schiavon, et al.. (1986). Pharmacodynamic assessment of dihydroxyprogesterone acetophenide plus estradiol enanthate as a monthly injectable contraceptive. Contraception. 33(6). 579–589. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jyothsna Visweswaraiah Breakdown of academic impact, for papers by Yuwen Linda Lin Breakdown of academic impact, for papers by Mika Kamata‐Sakurai Breakdown of academic impact, for papers by Shannon M. Wilson Breakdown of academic impact, for papers by Eric J. Hsu Breakdown of academic impact, for papers by Atsuhiko Maeda Breakdown of academic impact, for papers by Stephen Jarantow Breakdown of academic impact, for papers by Ruizhan Tong Breakdown of academic impact, for papers by Taylor Kalomeris Breakdown of academic impact, for papers by Shihong Li
Rankless by CCL
2026